Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Daybreak

Daybreak artwork

Why Indian pharma isn't scared of a 100% tariff (yet)

Jul 28, 202618 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Last Tuesday, Trump announced 100% tariffs on generic medicines imported into the US. By Wednesday, Indian pharma stocks were already falling even though the tariff doesn't take effect for two years. Trump wants import companies to reshore their manufacturing to the US so that the country can secure life-saving medication in the event of global supply chain disruptions. India supplies nearly 50% of all generic medicines consumed in America - birth control, antidepressants, hypertension treatments. The companies most exposed say shifting manufacturing to the US in two years isn't realistic. Building a viable generics ecosystem there takes at least five. But someone has to absorb the cost. And Indian companies have already said that moving is not a realistic plan - for now. Which means the ones picking up the bill are not the ones Trump thinks. Tune in. Take the Daybreak listener survey here. Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Hosts

  • Rachel Varghese Host Feed-stated

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. How Jio’s listing can put Mukesh Ambani’s “one indivisible Reliance” to the test

    Nov 19, 20269 minAudio

    Jio Platforms' IPO puts the spotlight on its close business relationship with Reliance Retail. The retailer is the sole distributor of Jio's prepaid connections, accounting for a substantial share of the telecom...

    Credit the people on this episode

  2. The UPI shortcut to US stocks is all gas and no brakes

    Nov 19, 202611 minAudio

    More and more Indians want a piece of American stocks, and the legal way in has become easier this year. But it’s still slow, and it doesn’t let you borrow to bet bigger. So a set of crypto platforms has stepped into...

    Credit the people on this episode

  3. India cut the tax on Scotch. Customs is now asking: what counts as Scotch?

    Nov 18, 202613 minAudio

    India drinks more whisky than any country on earth. Yet, pure Scotch makes up only about 3% of the whisky Indians drink. And now, dozens of containers of it sit stuck at Indian ports. Today, host Rachel Varghese unpacks...

    Credit the people on this episode

  4. Hospitals won’t pay for India’s medical inflation and insurers can’t

    Nov 17, 20269 minAudio

    India’s insurance regulator, Irdai, got over 2 lakh comments on its plan to cut agent commissions. It is expected to revise the proposals by December. The plan responds to medical costs rising 12-14% a year. Insurers...

    Credit the people on this episode

  5. Why global betting giants are paying Indian data scouts to see games before bettors

    Nov 15, 202612 minAudio

    Gavin's job involves a seat in a stadium, two phones and only a few seconds to log everything that happens on the pitch. He's a sports data scout in Guwahati. And the data he records is what ends up on going to global...

    Credit the people on this episode